NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Article
Tsien, Christina I, Pugh, Stephanie L, Dicker, Adam P et al. (2023). NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
. JOURNAL OF CLINICAL ONCOLOGY, 41(6), 1285-+. 10.1200/JCO.22.00164
Tsien, Christina I, Pugh, Stephanie L, Dicker, Adam P et al. (2023). NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
. JOURNAL OF CLINICAL ONCOLOGY, 41(6), 1285-+. 10.1200/JCO.22.00164
Tsien, Christina I; Pugh, Stephanie L; Dicker, Adam P; Raizer, Jeffrey J; Matuszak, Martha M; Lallana, Enrico C; Huang, Jiayi; Algan, Ozer; Deb, Nimisha; Portelance, Lorraine; Villano, John L; Hamm, John T; Oh, Kevin S; Ali, Arif N; Kim, Michelle M; Lindhorst, Scott M; Mehta, Minesh P